{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:24:17Z","timestamp":1790821457824,"version":"4.1.0"},"reference-count":73,"publisher":"The Endocrine Society","issue":"4","license":[{"start":{"date-parts":[[2020,12,31]],"date-time":"2020-12-31T00:00:00Z","timestamp":1609372800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"European Union\u2019s Horizon 2020","award":["633983"],"award-info":[{"award-number":["633983"]}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["314061271"],"award-info":[{"award-number":["314061271"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,3,25]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Context<\/jats:title><jats:p>Identification of patients with endocrine forms of hypertension (EHT) (primary hyperaldosteronism [PA], pheochromocytoma\/paraganglioma [PPGL], and Cushing syndrome [CS]) provides the basis to implement individualized therapeutic strategies. Targeted metabolomics (TM) have revealed promising results in profiling cardiovascular diseases and endocrine conditions associated with hypertension.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>Use TM to identify distinct metabolic patterns between primary hypertension (PHT) and EHT and test its discriminating ability.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Retrospective analyses of PHT and EHT patients from a European multicenter study (ENSAT-HT). TM was performed on stored blood samples using liquid chromatography mass spectrometry. To identify discriminating metabolites a \u201cclassical approach\u201d (CA) (performing a series of univariate and multivariate analyses) and a \u201cmachine learning approach\u201d (MLA) (using random forest) were used.<\/jats:p><jats:p>The study included 282 adult patients (52% female; mean age 49 years) with proven PHT (n = 59) and EHT (n = 223 with 40 CS, 107 PA, and 76 PPGL), respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>From 155 metabolites eligible for statistical analyses, 31 were identified discriminating between PHT and EHT using the CA and 27 using the MLA, of which 16 metabolites (C9, C16, C16:1, C18:1, C18:2, arginine, aspartate, glutamate, ornithine, spermidine, lysoPCaC16:0, lysoPCaC20:4, lysoPCaC24:0, PCaeC42:0, SM C18:1, SM C20:2) were found by both approaches. The receiver operating characteristic curve built on the top 15 metabolites from the CA provided an area under the curve (AUC) of 0.86, which was similar to the performance of the 15 metabolites from MLA (AUC 0.83).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>TM identifies distinct metabolic pattern between PHT and EHT providing promising discriminating performance.<\/jats:p><\/jats:sec>","DOI":"10.1210\/clinem\/dgaa954","type":"journal-article","created":{"date-parts":[[2020,12,31]],"date-time":"2020-12-31T18:50:52Z","timestamp":1609440652000},"page":"e1111-e1128","source":"Crossref","is-referenced-by-count":43,"title":["Targeted Metabolomics as a Tool in Discriminating Endocrine From Primary Hypertension"],"prefix":"10.1210","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6953-9133","authenticated-orcid":false,"given":"Zoran","family":"Erlic","sequence":"first","affiliation":[{"name":"Klinik f\u00fcr Endokrinologie, Diabetologie und Klinische Ern\u00e4hrung, Universit\u00e4tsSpital Z\u00fcrich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parminder","family":"Reel","sequence":"additional","affiliation":[{"name":"Division of Population Health and Genomics, School of Medicine, University of Dundee, Dundee, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smarti","family":"Reel","sequence":"additional","affiliation":[{"name":"Division of Population Health and Genomics, School of Medicine, University of Dundee, Dundee, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3942-4276","authenticated-orcid":false,"given":"Laurence","family":"Amar","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Paris, PARCC, INSERM, Paris, France"},{"name":"Assistance Publique-H\u00f4pitaux de Paris, H\u00f4pital Europ\u00e9en Georges Pompidou, Unit\u00e9 Hypertension art\u00e9rielle, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Pecori","sequence":"additional","affiliation":[{"name":"Division of Internal Medicine and Hypertension Unit, Department of Medical Sciences, University of Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casper K","family":"Larsen","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Paris, PARCC, INSERM, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Tetti","sequence":"additional","affiliation":[{"name":"Division of Internal Medicine and Hypertension Unit, Department of Medical Sciences, University of Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0772-1604","authenticated-orcid":false,"given":"Christina","family":"Pamporaki","sequence":"additional","affiliation":[{"name":"Institute of Clinical Chemistry and Laboratory Medicine, Universit\u00e4tsklinikum Carl Gustav Carus, Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1274-4715","authenticated-orcid":false,"given":"Cornelia","family":"Prehn","sequence":"additional","affiliation":[{"name":"Research Unit Molecular Endocrinology and Metabolism, Genome Analysis Center, Helmholtz Zentrum M\u00fcnchen, German Research Center for Environmental Health, Neuherberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9259-0199","authenticated-orcid":false,"given":"Jerzy","family":"Adamski","sequence":"additional","affiliation":[{"name":"Research Unit Molecular Endocrinology and Metabolism, Genome Analysis Center, Helmholtz Zentrum M\u00fcnchen, German Research Center for Environmental Health, Neuherberg, Germany"},{"name":"Lehrstuhl f\u00fcr Experimentelle Genetik, Technische Universit\u00e4t M\u00fcnchen, Freising-Weihenstephan, Germany"},{"name":"Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, 8 Medical Drive, Singapore, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7085-0244","authenticated-orcid":false,"given":"Aleksander","family":"Prejbisz","sequence":"additional","affiliation":[{"name":"Department of Hypertension, National Institute of Cardiology, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1456-8716","authenticated-orcid":false,"given":"Filippo","family":"Ceccato","sequence":"additional","affiliation":[{"name":"UOC Endocrinologia, Dipartimento di Medicina DIMED, Azienda Ospedaliera-Universit\u00e0 di Padova, Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9396-3815","authenticated-orcid":false,"given":"Carla","family":"Scaroni","sequence":"additional","affiliation":[{"name":"UOC Endocrinologia, Dipartimento di Medicina DIMED, Azienda Ospedaliera-Universit\u00e0 di Padova, Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7628-3161","authenticated-orcid":false,"given":"Matthias","family":"Kroiss","sequence":"additional","affiliation":[{"name":"Clinical Chemistry and Laboratory Medicine, Core Unit Clinical Mass Spectrometry, Universit\u00e4tsklinikum W\u00fcrzburg, Germany"},{"name":"Schwerpunkt Endokrinologie\/Diabetologie, Medizinische Klinik und Poliklinik I, Universit\u00e4tsklinikum W\u00fcrzburg, Germany"},{"name":"Comprehensive Cancer Center Mainfranken, Universit\u00e4t W\u00fcrzburg, W\u00fcrzburg, Germany"},{"name":"Medizinische Klinik und Poliklinik IV, Klinikum der Universit\u00e4t M\u00fcnchen, LMU M\u00fcnchen, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C","family":"Dennedy","sequence":"additional","affiliation":[{"name":"The Discipline of Pharmacology and Therapeutics, School of Medicine, National University of Ireland 33 Galway, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2465-1986","authenticated-orcid":false,"given":"Jaap","family":"Deinum","sequence":"additional","affiliation":[{"name":"Department of Medicine, Section of Vascular Medicine, Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9333-5499","authenticated-orcid":false,"given":"Katharina","family":"Langton","sequence":"additional","affiliation":[{"name":"Institute of Clinical Chemistry and Laboratory Medicine, Universit\u00e4tsklinikum Carl Gustav Carus, Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5480-1116","authenticated-orcid":false,"given":"Paolo","family":"Mulatero","sequence":"additional","affiliation":[{"name":"Division of Internal Medicine and Hypertension Unit, Department of Medical Sciences, University of Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9817-9875","authenticated-orcid":false,"given":"Martin","family":"Reincke","sequence":"additional","affiliation":[{"name":"Medizinische Klinik und Poliklinik IV, Klinikum der Universit\u00e4t M\u00fcnchen, LMU M\u00fcnchen, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6146-3015","authenticated-orcid":false,"given":"Livia","family":"Lenzini","sequence":"additional","affiliation":[{"name":"Clinica dell\u2019Ipertensione Arteriosa, Department of Medicine-DIMED, University of Padua, Padua"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4816-670X","authenticated-orcid":false,"given":"Anne-Paule","family":"Gimenez-Roqueplo","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Paris, PARCC, INSERM, Paris, France"},{"name":"Assistance Publique-H\u00f4pitaux de Paris, H\u00f4pital Europ\u00e9en Georges Pompidou, Service de G\u00e9n\u00e9tique, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Assi\u00e9","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Paris, Institut Cochin, INSERM, CNRS, PARIS, France"},{"name":"Department of Endocrinology, Center for Rare Adrenal Diseases, AP-HP, H\u00f4pital Cochin, Paris, France"},{"name":"Department of Endocrinology, Center for Rare Adrenal Diseases, Assistance Publique\u2013H\u00f4pitaux de Paris, H\u00f4pital Cochin, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0815-0586","authenticated-orcid":false,"given":"Anne","family":"Blanchard","sequence":"additional","affiliation":[{"name":"Assistance Publique-H\u00f4pitaux de Paris, H\u00f4pital Europ\u00e9en Georges Pompidou, Centre d\u2019Investigations Cliniques 9201, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Christina","family":"Zennaro","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Paris, PARCC, INSERM, Paris, France"},{"name":"Assistance Publique-H\u00f4pitaux de Paris, H\u00f4pital Europ\u00e9en Georges Pompidou, Service de G\u00e9n\u00e9tique, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2992-7582","authenticated-orcid":false,"given":"Emily","family":"Jefferson","sequence":"additional","affiliation":[{"name":"Division of Population Health and Genomics, School of Medicine, University of Dundee, Dundee, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7826-3984","authenticated-orcid":false,"given":"Felix","family":"Beuschlein","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Endokrinologie, Diabetologie und Klinische Ern\u00e4hrung, Universit\u00e4tsSpital Z\u00fcrich, Zurich, Switzerland"},{"name":"Medizinische Klinik und Poliklinik IV, Klinikum der Universit\u00e4t M\u00fcnchen, LMU M\u00fcnchen, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2020,12,31]]},"reference":[{"issue":"9455","key":"2021122205214372400_CIT0001","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0140-6736(05)17741-1","article-title":"Global burden of hypertension: analysis of worldwide data","volume":"365","author":"Kearney","year":"2005","journal-title":"Lancet."},{"issue":"6","key":"2021122205214372400_CIT0002","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/CIRCULATIONAHA.115.018912","article-title":"Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries","volume":"134","author":"Mills","year":"2016","journal-title":"Circulation."},{"issue":"2","key":"2021122205214372400_CIT0003","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1161\/CIRCULATIONAHA.117.032582","article-title":"Potential US population impact of the 2017 ACC\/AHA high blood pressure guideline","volume":"137","author":"Muntner","year":"2018","journal-title":"Circulation."},{"key":"2021122205214372400_CIT0004","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1161\/CIRCULATIONAHA.117.032890","article-title":"Global impact of 2017 American College of Cardiology\/American Heart Association hypertension guidelines: a perspective from China","volume":"137","author":"Wang","year":"2018","journal-title":"Circulation."},{"key":"2021122205214372400_CIT0005","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1001\/jama.2010.650","article-title":"US trends in prevalence, awareness, treatment, and control of hypertension, 1988\u20132008","volume":"303","author":"Egan","year":"2010","journal-title":"JAMA."},{"key":"2021122205214372400_CIT0006","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijcard.2016.05.044","article-title":"Lack of control of hypertension in primary cardiovascular disease prevention in Europe: results from the EURIKA study","volume":"218","author":"Borghi","year":"2016","journal-title":"Int J Cardiol."},{"issue":"1","key":"2021122205214372400_CIT0007","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1161\/01.HYP.0000103630.72812.10","article-title":"Hypertension treatment and control in five European countries, Canada, and the United States","volume":"43","author":"Wolf-Maier","year":"2004","journal-title":"Hypertension."},{"issue":"3","key":"2021122205214372400_CIT0008","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1291\/hypres.27.193","article-title":"Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan","volume":"27","author":"Omura","year":"2004","journal-title":"Hypertens Res."},{"key":"2021122205214372400_CIT0009","first-page":"8295010","article-title":"Detection of secondary causes and coexisting diseases in hypertensive patients: OSA and PA are the common causes associated with hypertension","volume":"2017","author":"Wang","year":"2017","journal-title":"Biomed Res Int."},{"issue":"14","key":"2021122205214372400_CIT0010","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","article-title":"Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice","volume":"69","author":"Monticone","year":"2017","journal-title":"J Am Coll Cardiol."},{"issue":"1","key":"2021122205214372400_CIT0011","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7326\/M20-0065","article-title":"The unrecognized prevalence of primary aldosteronism: a cross-sectional study","volume":"173","author":"Brown","year":"2020","journal-title":"Ann Intern Med."},{"issue":"9","key":"2021122205214372400_CIT0012","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S2213-8587(17)30135-3","article-title":"Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort","volume":"5","author":"Williams","year":"2017","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"11","key":"2021122205214372400_CIT0013","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1055\/s-0035-1559645","article-title":"Cost-effectiveness analysis of the diagnosis and treatment of primary aldosteronism in Japan","volume":"47","author":"Sato","year":"2015","journal-title":"Horm Metab Res."},{"issue":"5","key":"2021122205214372400_CIT0014","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society Clinical Practice Guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab."},{"key":"2021122205214372400_CIT0015","article-title":"Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension","author":"Mulatero","year":"2020","journal-title":"J Hypertens."},{"key":"2021122205214372400_CIT0016","first-page":"Unit 30","article-title":"Targeted metabolomics","volume":"Chapter 30","author":"Roberts","year":"2012","journal-title":"Curr Protoc Mol Biol."},{"issue":"1","key":"2021122205214372400_CIT0017","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1021\/acs.analchem.6b02930","article-title":"Interlaboratory reproducibility of a targeted metabolomics platform for analysis of human serum and plasma","volume":"89","author":"Siskos","year":"2017","journal-title":"Anal Chem."},{"issue":"6","key":"2021122205214372400_CIT0018","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1093\/ajcn\/87.6.1860","article-title":"Consequences of low plasma histidine in chronic kidney disease patients: associations with inflammation, oxidative stress, and mortality","volume":"87","author":"Watanabe","year":"2008","journal-title":"Am J Clin Nutr."},{"issue":"1","key":"2021122205214372400_CIT0019","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1017\/S0007114511005289","article-title":"Histidine and arginine are associated with inflammation and oxidative stress in obese women","volume":"108","author":"Niu","year":"2012","journal-title":"Br J Nutr."},{"issue":"25","key":"2021122205214372400_CIT0020","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1016\/j.jacc.2016.09.972","article-title":"The emerging role of metabolomics in the diagnosis and prognosis of cardiovascular disease","volume":"68","author":"Ussher","year":"2016","journal-title":"J Am Coll Cardiol."},{"issue":"2","key":"2021122205214372400_CIT0021","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2337\/db12-0495","article-title":"Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach","volume":"62","author":"Floegel","year":"2013","journal-title":"Diabetes."},{"issue":"10","key":"2021122205214372400_CIT0022","doi-asserted-by":"crossref","first-page":"e78430","DOI":"10.1371\/journal.pone.0078430","article-title":"Plasma metabolomics reveal alterations of sphingo- and glycerophospholipid levels in non-diabetic carriers of the transcription factor 7-like 2 polymorphism rs7903146","volume":"8","author":"Then","year":"2013","journal-title":"PLoS One."},{"issue":"3","key":"2021122205214372400_CIT0023","doi-asserted-by":"crossref","first-page":"605","DOI":"10.2337\/DC11-1577","article-title":"Metabolomic profiling of fatty acid and amino acid metabolism in youth with obesity and type 2 diabetes: evidence for enhanced mitochondrial oxidation","volume":"35","author":"Mihalik","year":"2012","journal-title":"Diabetes Care."},{"issue":"3","key":"2021122205214372400_CIT0024","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41366-018-0132-z","article-title":"Plasma metabolites reveal distinct profiles associating with different metabolic risk factors in monozygotic twin pairs","volume":"43","author":"Muniandy","year":"2019","journal-title":"Int J Obes (Lond)."},{"issue":"2","key":"2021122205214372400_CIT0025","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1530\/EJE-17-0109","article-title":"Cortisol-related metabolic alterations assessed by mass spectrometry assay in patients with Cushing\u2019s syndrome","volume":"177","author":"Di Dalmazi","year":"2017","journal-title":"Eur J Endocrinol."},{"issue":"6","key":"2021122205214372400_CIT0026","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1530\/EJE-19-0589","article-title":"Metabolic impact of pheochromocytoma\/paraganglioma: targeted metabolomics in patients before and after tumor removal","volume":"181","author":"Erlic","year":"2019","journal-title":"Eur J Endocrinol."},{"issue":"6","key":"2021122205214372400_CIT0027","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"key":"2021122205214372400_CIT0028","first-page":"842","article-title":"Comments on the 2013 ESH\/ESC guidelines for the management of arterial hypertension. a report of the task force of the clinical practice guidelines committee of the Spanish Society of Cardiology","volume":"66","author":"Saanchez","year":"2013","journal-title":"Rev Esp Cardiol."},{"issue":"8","key":"2021122205214372400_CIT0029","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1097\/HJH.0000000000002438","article-title":"Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension","volume":"38","author":"Lenders","year":"2020","journal-title":"J Hypertens."},{"key":"2021122205214372400_CIT0030","article-title":"Supplemental data from: targeted metabolomics as a tool in discriminating endocrine from primary hypertension","author":"Erlic","year":"2020","journal-title":"ZORA Repository."},{"key":"2021122205214372400_CIT0031","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s11306-011-0293-4","article-title":"Procedure for tissue sample preparation and metabolite extraction for high-throughput targeted metabolomics","volume":"8","author":"Romisch-Margl","year":"2012","journal-title":"Metabolomics."},{"key":"2021122205214372400_CIT0032","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1007\/s10337-013-2429-3","article-title":"Targeted metabolomics of dried blood spot extracts","volume":"76","author":"Zukunft","year":"2013","journal-title":"Chromatographia."},{"key":"2021122205214372400_CIT0033","volume-title":"Guideline on bioanalytical method validation.","author":"Committee for Medicinal Products for Human Use (CHMP)"},{"issue":"6","key":"2021122205214372400_CIT0034","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/bioinformatics\/17.6.520","article-title":"Missing value estimation methods for DNA microarrays","volume":"17","author":"Troyanskaya","year":"2001","journal-title":"Bioinformatics."},{"key":"2021122205214372400_CIT0035","doi-asserted-by":"crossref","first-page":"14.10.11","DOI":"10.1002\/cpbi.11","article-title":"Using MetaboAnalyst 3.0 for comprehensive metabolomics data analysis","volume":"55","author":"Xia","year":"2016","journal-title":"Curr Protoc Bioinformatics."},{"issue":"Suppl 1","key":"2021122205214372400_CIT0036","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1093\/bioinformatics\/18.suppl_1.S105","article-title":"A variance-stabilizing transformation for gene-expression microarray data","volume":"18","author":"Durbin","year":"2002","journal-title":"Bioinformatics."},{"issue":"3","key":"2021122205214372400_CIT0037","doi-asserted-by":"crossref","first-page":"e0173615","DOI":"10.1371\/journal.pone.0173615","article-title":"The human plasma-metabolome: reference values in 800 French healthy volunteers; impact of cholesterol, gender and age","volume":"12","author":"Trabado","year":"2017","journal-title":"PLoS One."},{"issue":"8","key":"2021122205214372400_CIT0038","doi-asserted-by":"crossref","first-page":"e1002215","DOI":"10.1371\/journal.pgen.1002215","article-title":"Discovery of sexual dimorphisms in metabolic and genetic biomarkers","volume":"7","author":"Mittelstrass","year":"2011","journal-title":"PLoS Genet."},{"key":"2021122205214372400_CIT0039","article-title":"Binomial logistic regression using SPSS statistics","volume-title":"Statistical tutorials and software guides","author":"Leard_Statistics","year":"2017"},{"key":"2021122205214372400_CIT0040","doi-asserted-by":"crossref","DOI":"10.1145\/3056662.3056671","article-title":"Improved information gain feature selection method for Chinese text classification based on word embedding","volume-title":"6th International Conference on Software and Computer Applications (ICSCA)","author":"Zhu"},{"key":"2021122205214372400_CIT0041","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1023\/A:1010933404324","article-title":"Random forests","volume":"45","author":"Breiman","year":"2001","journal-title":"Mach Learn."},{"key":"2021122205214372400_CIT0042","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1214\/09-SS054","article-title":"A survey of cross-validation procedures for model selection","volume":"4","author":"Arlot","year":"2010","journal-title":"Statistics Surveys."},{"key":"2021122205214372400_CIT0043","first-page":"2349","article-title":"Orange: data mining toolbox in Python","volume":"14","author":"Demsar","year":"2013","journal-title":"J Mach Learn Res."},{"issue":"8","key":"2021122205214372400_CIT0044","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"Milliez","year":"2005","journal-title":"J Am Coll Cardiol."},{"issue":"1","key":"2021122205214372400_CIT0045","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","article-title":"Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis","volume":"6","author":"Monticone","year":"2018","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"5","key":"2021122205214372400_CIT0046","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1055\/s-0032-1306294","article-title":"High incidence of cardiovascular complications in pheochromocytoma","volume":"44","author":"Zelinka","year":"2012","journal-title":"Horm Metab Res."},{"issue":"3","key":"2021122205214372400_CIT0047","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1210\/jc.2012-3669","article-title":"Is the excess cardiovascular morbidity in pheochromocytoma related to blood pressure or to catecholamines?","volume":"98","author":"Stolk","year":"2013","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2021122205214372400_CIT0048","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41581-019-0244-2","article-title":"The global epidemiology of hypertension","volume":"16","author":"Mills","year":"2020","journal-title":"Nat Rev Nephrol."},{"issue":"2","key":"2021122205214372400_CIT0049","doi-asserted-by":"crossref","first-page":"E4","DOI":"10.3171\/2014.11.FOCUS14704","article-title":"Pitfalls in the diagnosis and management of Cushing\u2019s syndrome","volume":"38","author":"Bansal","year":"2015","journal-title":"Neurosurg Focus."},{"issue":"10","key":"2021122205214372400_CIT0050","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/nrendo.2015.129","article-title":"Acylcarnitines\u2013old actors auditioning for new roles in metabolic physiology","volume":"11","author":"McCoin","year":"2015","journal-title":"Nat Rev Endocrinol."},{"issue":"5","key":"2021122205214372400_CIT0051","doi-asserted-by":"crossref","first-page":"e0124844","DOI":"10.1371\/journal.pone.0124844","article-title":"Metabolomic fingerprint of heart failure with preserved ejection fraction","volume":"10","author":"Zordoky","year":"2015","journal-title":"PLoS One."},{"issue":"6","key":"2021122205214372400_CIT0052","doi-asserted-by":"crossref","first-page":"e000542","DOI":"10.1161\/JAHA.113.000542","article-title":"A plasma long-chain acylcarnitine predicts cardiovascular mortality in incident dialysis patients","volume":"2","author":"Kalim","year":"2013","journal-title":"J Am Heart Assoc."},{"issue":"1","key":"2021122205214372400_CIT0053","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2337\/db12-0466","article-title":"Acylcarnitines: reflecting or inflicting insulin resistance?","volume":"62","author":"Schooneman","year":"2013","journal-title":"Diabetes."},{"issue":"2-03","key":"2021122205214372400_CIT0054","first-page":"129","article-title":"Metabolic alterations in patients with pheochromocytoma","volume":"127","author":"Erlic","year":"2019","journal-title":"Exp Clin Endocrinol Diabetes."},{"issue":"5","key":"2021122205214372400_CIT0055","doi-asserted-by":"crossref","first-page":"938","DOI":"10.2337\/dc18-1293","article-title":"High prevalence of diabetes in patients with primary Aldosteronism (PA) associated with subclinical hypercortisolism and prediabetes more prevalent in bilateral than unilateral PA: a large, multicenter cohort study in Japan","volume":"42","author":"Akehi","year":"2019","journal-title":"Diabetes Care."},{"issue":"Pt 1","key":"2021122205214372400_CIT0056","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj20031327","article-title":"A perspective of polyamine metabolism","volume":"376","author":"Wallace","year":"2003","journal-title":"Biochem J."},{"issue":"1","key":"2021122205214372400_CIT0057","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00726-010-0489-3","article-title":"Metabolic correlations of glucocorticoids and polyamines in inflammation and apoptosis","volume":"39","author":"Bjelakovi\u0107","year":"2010","journal-title":"Amino Acids."},{"issue":"15","key":"2021122205214372400_CIT0058","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.jacc.2015.02.018","article-title":"Metabolic disturbances identified in plasma are associated with outcomes in patients with heart failure: diagnostic and prognostic value of metabolomics","volume":"65","author":"Cheng","year":"2015","journal-title":"J Am Coll Cardiol."},{"issue":"6","key":"2021122205214372400_CIT0059","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.yjmcc.2006.03.002","article-title":"Involvement of polyamines in apoptosis of cardiac myoblasts in a model of simulated ischemia","volume":"40","author":"Tantini","year":"2006","journal-title":"J Mol Cell Cardiol."},{"issue":"3","key":"2021122205214372400_CIT0060","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.pharmthera.2013.07.004","article-title":"Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets?","volume":"140","author":"Rochette","year":"2013","journal-title":"Pharmacol Ther."},{"issue":"5","key":"2021122205214372400_CIT0061","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00011-018-1129-8","article-title":"Vascular endothelium dysfunction: a conservative target in metabolic disorders","volume":"67","author":"Jamwal","year":"2018","journal-title":"Inflamm Res."},{"issue":"3 Pt 1","key":"2021122205214372400_CIT0062","first-page":"E501","article-title":"Effect of cortisol on energy expenditure and amino acid metabolism in humans","volume":"268","author":"Brillon","year":"1995","journal-title":"Am J Physiol."},{"issue":"2","key":"2021122205214372400_CIT0063","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s11102-014-0631-4","article-title":"Clinical and biochemical manifestations of Cushing\u2019s","volume":"18","author":"Ntali","year":"2015","journal-title":"Pituitary."},{"issue":"6","key":"2021122205214372400_CIT0064","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/j.1365-2265.2011.04148.x","article-title":"Mineralocorticoid antagonism: a novel way to treat sarcopenia and physical impairment in older people?","volume":"75","author":"Burton","year":"2011","journal-title":"Clin Endocrinol (Oxf)."},{"key":"2021122205214372400_CIT0065","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3389\/fendo.2019.00195","article-title":"The differential effect of excess aldosterone on skeletal muscle mass by sex","volume":"10","author":"Kwak","year":"2019","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"4","key":"2021122205214372400_CIT0066","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1007\/s00774-018-0959-3","article-title":"Change of skeletal muscle mass in patients with pheochromocytoma","volume":"37","author":"Lee","year":"2019","journal-title":"J Bone Miner Metab."},{"key":"2021122205214372400_CIT0067","doi-asserted-by":"crossref","first-page":"945","DOI":"10.2147\/NDT.S159855","article-title":"Elevated peripheral blood glutamate levels in major depressive disorder","volume":"14","author":"Inoshita","year":"2018","journal-title":"Neuropsychiatr Dis Treat."},{"issue":"3","key":"2021122205214372400_CIT0068","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1055\/s-0032-1301921","article-title":"Psychopathological symptoms in patients with primary hyperaldosteronism\u2013possible pathways","volume":"44","author":"K\u00fcnzel","year":"2012","journal-title":"Horm Metab Res."},{"issue":"30","key":"2021122205214372400_CIT0069","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.2174\/092986707782793899","article-title":"Role of lysophosphatidylcholine (LPC) in atherosclerosis","volume":"14","author":"Matsumoto","year":"2007","journal-title":"Curr Med Chem."},{"key":"2021122205214372400_CIT0070","doi-asserted-by":"crossref","first-page":"117443","DOI":"10.1016\/j.lfs.2020.117443","article-title":"The mechanisms of lysophosphatidylcholine in the development of diseases","volume":"247","author":"Liu","year":"2020","journal-title":"Life Sci."},{"issue":"1","key":"2021122205214372400_CIT0071","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.atherosclerosis.2012.08.041","article-title":"Sphingolipids and atherosclerosis","volume":"226","author":"Hornemann","year":"2013","journal-title":"Atherosclerosis."},{"issue":"1","key":"2021122205214372400_CIT0072","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s12859-018-2149-7","article-title":"Ensemble outlier detection and gene selection in triple-negative breast cancer data","volume":"19","author":"Lopes","year":"2018","journal-title":"BMC Bioinformatics."},{"key":"2021122205214372400_CIT0073","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.clinbiochem.2020.03.004","article-title":"After another decade: LC-MS\/MS became routine in clinical diagnostics","volume":"82","author":"Seger","year":"2020","journal-title":"Clin Biochem."}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgaa954\/35335367\/dgaa954.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/106\/4\/e1111\/41849336\/dgaa954.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/106\/4\/e1111\/41849336\/dgaa954.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,10]],"date-time":"2022-12-10T04:58:13Z","timestamp":1670648293000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/106\/4\/e1111\/6056647"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,31]]},"references-count":73,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,12,31]]},"published-print":{"date-parts":[[2021,3,25]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgaa954","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,4,1]]},"published":{"date-parts":[[2020,12,31]]}}}